Clinical Competition Candidate
CHLORHEXIDINE GLUCONATE
CHLORHEXIDINE GLUCONATE carries product and use-code patents, low complexity (1/5), and meaningful clinical competition (4/5). The listed expiry window is approximately 15 months away. Active clinical competition may compress the generic entry window.
LOE window
15months
to latest listed patent expiry (October 2, 2027)
Expiry attractiveness: 4/5
Patent profile
Substance patent (none)
Product / formulation patent (listed)
Use-code patent (listed)
Patent count: 2
Complexity score: 1/5
Clinical competition
Score: 4/5
Active trials linked: 300
Phase 2/3 trials: 56
Higher scores indicate more trial activity for this ingredient — a proxy for competitive generic interest.
Drug overview
Active ingredient: CHLORHEXIDINE GLUCONATE
Applicant (NDA holder): SAGE PRODUCTS INC
Confidence: High